Andrea Gallamini
机构: A. Lacassagne Cancer Center
每年引用次数
引用次数
引用: 18,487
H-指数: 66
I10-指数 : 153
出版物: 515
Upstaging by PET-ascertained bone and bone marrow involvement in Hodgkin lymphoma: definitions matter
C. Stelitano , Tarec Christoffer El-Galaly , F. D’Amore , A. Rago
International Symposium on Hodgkin Lymphoma
1
2013
Intestinal T-cell lymphoma with massive tissue and blood eosinophilia mediated by IL-5
G. Reato , D. Novero , P. Lista , G. Asnaghi
Leukemia & Lymphoma 17 155 -161
16
1995
Patterns of Bone/Bone-Marrow FDG-Uptake in Hodgkin Lymphoma Correlate to Outcome: a Review of 96 ABVD-Treated Patients
J. Darcourt , S. Chauvie , A. Gallamini , Tarec Christoffer El-Galaly
European Journal of Nuclear Medicine and Molecular Imaging 41
2014
Patterns of PET/CT-assessed bone-marrow involvement and prognosis in newly diagnosed Hodgkin lymphoma: A detailed review of 122 treated patients treated with ABVD
S. Chauvie , F. Bergesio , Tarec El-Galaly , Anna Borra
American Journal of Hematology 56 ( 5)
1
2015
[Pleural effusion in a case of non-Hodgkin's lymphoma: diagnostic use of molecular analysis].
M. Bonferroni , R. Foà , G. B. Cavallero , A. Gallamini
Recenti progressi in medicina 81 ( 9) 568 -570
1
1990
Intensive conventional chemotherapy can lead to a precocious overshoot of cytogenetically normal blood stem cells (BSC) in chronic myeloid leukemia and acute lymphoblastic leukemia.
A. Gallamini , A. M. Carella , M. Podesta , V. Vitale
Leukemia 6 120 -123
13
1992
High-dose ARA-C with autologous peripheral blood progenitor cell (PBPC) support induces a marked mobilization fostering the optimal harvest of circulating hemopoietic progenitors
F. Zallio , I. Ricca , A. Gallamini , M. Magni
Blood 96
2000
Preliminary results of a new chemotherapy regimen (vepemb) devised for elderly hodgkin's disease patients
U. Vitolo , E. Scassa , E. Cavalieri , M. Bertini
Blood 96 245
2000
Stage IV hodgkin's disease: unfavorable prognostic role of liver involvement
U. Vitolo , E. Scassa , B. Allione , F. Salvi
Blood 96
2000
Only focal bone marrow FDG uptake in baseline FDG Pet scan has a diagnostic and prognostic impact in Hodgkin Lymphoma
J. Darcourt , Stefano Luminari , W. Kulikowski , Tarec El-Galaly
Haematologica 101
2016
NONMYELOABLATIVE ALLOGRAFTING OR AUTOGRAFTING FOR NEWLY DIAGNOSED MULTIPLE MYELOMA
R. Sorasio , S. Bringhen , M. Massaia , G. Ciccone
Haematologica
2007
INCIDENCE OF INVASIVE ASPERGILLOSIS IN ALLOGENEIC STEM CELL TRANSPLANTATION RECIPIENTS: AN ITALIAN PROSPECTIVE MULTICENTER STUDY
R. Sorasio , M. Boccadoro , B. Allione , D. Mattei
Haematologica 0209 -0209
2007
A phase II study on intensive all type chemotherapy with minimal residual disease (MRD) oriented postremission strategy in adult patients with lymphoblastic lymphoma(PROTOCOL NILG-ALL NO.09/00)
A. Cortelezzi , E. Pogliani , A. Rambaldi , C. Romani
Congress of the European Hematology Association 93 305 -305
2008
Prognosi e terapia del mieloma multiplo.
M. Tribalto , T. Barbui , G. Avvisati , L. Resegotti
115 -124
1989
Tandem autografting-nonmyeloablative allografting for newly diagnosed multiple myeloma: The GITMO (gruppo italiano trapianto midollo osseo) experience
R. Sorasio , V. Montefusco , Massimo Massaia , E. Pogliani
EHA European Hematology Association 92 ( 1) 0403 -0403
2007
The Prognostic value of tumor and microenvironment markers in classifical Hodgkin lymphoma (CHL) patients.
C. Stelitano , U. Vitolo , Luisa Stracqualursi , Lisa Argnani
Congresso della Società Italiana di Ematologia, 26 -26
2011
Patients with classical Hodgkin lymphoma (CHL) and treatment failure despite a negative iPET have poor outcomes as patients with positive iPET and treatment escalation
J.M. Zaucha , W. Khair , P. Biecek , E. Subocz
Hematological Oncology 35 313 -315
2017
Disease and Comorbidity Status Predict Outcome after Nonmyeloablative Allografting for Advanced Haematological Malignancies.
A. Bosi , Mario Boccadoro , B. Bruno , R. Sorasio
Blood 110 ( 11) 4930 -4930
2007
Allogeneic bone marrow transplantation in multiple myeloma.
A. Gallamini , F. Buffa , A. Bacigalupo , M.T. Van Lint
Acta Haematologica 77 ( 2) 111 -114
5
1987
P-34 Different modalities of bonemarrow blast quantification can influence diagnostic and prognostic evaluation of myelodysplastic syndromes (MDS)
F. Salvi , L. Godio , E. Campa , M.M. Ciriello
Leukemia Research 29
2005